# Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

Study · id `cardio:ct-nct03940066` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03940066](<https://clinicaltrials.gov/study/NCT03940066>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03940066

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 169 participants.

## Technical summary

Registry record NCT03940066. Randomized; no masking; primary purpose prevention. Start 2019-11-12 (actual); primary completion 2024-04-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 169 participants (enrolled count; ClinicalTrials.gov record NCT03940066, source copy `cardio:ctgov-nct03940066-2025-04-06`, retrieved 2026-10-26)
- Started: 2019-11-12 (actual) (ClinicalTrials.gov record NCT03940066, source copy `cardio:ctgov-nct03940066-2025-04-06`, retrieved 2026-10-26)
- Primary completion: 2024-04-08 (actual) (ClinicalTrials.gov record NCT03940066, source copy `cardio:ctgov-nct03940066-2025-04-06`, retrieved 2026-10-26)
- Completion: 2024-06-01 (actual) (ClinicalTrials.gov record NCT03940066, source copy `cardio:ctgov-nct03940066-2025-04-06`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03940066, source copy `cardio:ctgov-nct03940066-2025-04-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03940066-2025-04-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile
- Acronym: Monitor- ACS
- Condition: Atrial Fibrillation
- Condition: Syncope
- Condition: Tachycardia
- Condition: Arrhythmias, Cardiac
- Condition: Heart Diseases
- Intervention (Device): Biomonitor-2 and Kardia mobile
- Intervention (Other): No Intervention
- Lead sponsor: Fundación EPIC
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Fundación EPIC (`cardio:org-fundacion-epic`)

## Provenance

Content hash: d5eb8c6c3e514b010112ce97a134d6a7d50d5b96dff1f70b0afaba10c0406bd6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
